Genocea Biosciences Current Assets

Genocea Biosciences (GNCA) currently reports a current assets of $24M as of March 2022. That compares with $69M in the prior-year period — down 64.5% year over year. Use the charts on this page to explore Genocea Biosciences's current assets history and peer comparisons.

Genocea Biosciences's current assets decreased from $69M to $24M — a 64.5% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genocea Biosciences reported $24M in current assets as of March 2022. That compares with $69M in the prior-year period — down 64.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Genocea Biosciences, and consider following GNCA for alerts when major investors trade the stock.

Genocea Biosciences is classified in the Healthcare sector. On current assets, it currently shows $24M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GNCA with unrelated industries.